Ipca Laboratories Limited Ipca Laboratories Limited

Ipca Laboratories Limited

IPCALAB

Classifica tra le azioni #3404
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Prezzo delle azioni
$20.02
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$5.08B
Variazione (1 giorno)
-1.65%
Variazione (1 anno)
38.46%
Paese
IN
Scambia Ipca Laboratories Limited (IPCALAB)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Ipca Laboratories Limited (IPCALAB)
L’azione Ipca Laboratories Limited (simbolo: IPCALAB) ha subito un totale di 3 frazionamenti.
L’ultimo frazionamento è avvenuto il Jan 10, 2022.
Una quota di IPCALAB acquistata prima di Jan 28, 2005 equivale oggi a 20 quote di IPCALAB.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
2022-01-10 2:1 x2 x20
2010-03-22 5:1 x5 x10
2005-01-28 2:1 x2 x2
Frazionamenti azionari di aziende simili o concorrenti